Interleukin 10 Cooperates with Interleukin 4 to Suppress Inflammatory Cytokine Production by Freshly Prepared Adherent Rheumatoid Synovial Cells
Overview
Affiliations
Objective: Inflammatory cytokines have been implicated as important mediators of inflammation in rheumatoid arthritis (RA). We investigated whether interleukin 4 (IL-4) and interleukin 10 (IL-10) suppress the production of inflammatory cytokines by freshly prepared adherent rheumatoid synovial cells.
Methods: Adherent synovial cells were obtained from the rheumatoid synovium by collagenase digestion. The levels of IL-1 beta, tumor necrosis factor-alpha (TNF-alpha), IL-6, and IL-8 in culture supernatants were measured by ELISA. The gene expression of IL-6 and IL-8 were determined by Northern blot analysis.
Results: Freshly prepared rheumatoid synovial cells spontaneously produced large amounts of IL-6 and IL-8. However, the amounts of IL-1 beta and TNF-alpha produced were approximately 1000-fold less than those of IL-6 and IL-8. IL-4 alone inhibited the production of IL-1 beta, IL-6, and IL-8 by 32, 35, and 50%, respectively. IL-10 alone was less potent than IL-4 in suppressing these cytokines. Of note, the combination of IL-4 and IL-10 cooperatively exerted potent suppressive effects on the production of IL-1 beta, IL-6, and IL-8 by 74.3, 69, and 77%, respectively. The suppressive effects of the combination of IL-4 and IL-10 on IL-6 and IL-8 were also observed at the levels of mRNA.
Conclusion: These results suggest that combination of IL-4 and IL-10 may be capable of suppressing the production of inflammatory cytokines at rheumatoid inflammatory joints.
The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation.
Fan D, Guo Q, Shen J, Zheng K, Lu C, Zhang G Int J Mol Sci. 2018; 19(2).
PMID: 29373547 PMC: 5855598. DOI: 10.3390/ijms19020376.
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.
Wythe S, DiCara D, Taher T, Finucane C, Jones R, Bombardieri M Ann Rheum Dis. 2012; 72(1):129-35.
PMID: 22843486 PMC: 3551226. DOI: 10.1136/annrheumdis-2012-201457.
Lim D, Bae Y Rheumatol Int. 2011; 31(7):843-7.
PMID: 21327427 DOI: 10.1007/s00296-011-1818-x.
Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis.
Hahn Y, Kim J Korean J Pediatr. 2011; 53(11):921-30.
PMID: 21218013 PMC: 3012271. DOI: 10.3345/kjp.2010.53.11.921.
Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution.
Kuek A, Hazleman B, Ostor A Postgrad Med J. 2007; 83(978):251-60.
PMID: 17403952 PMC: 2600039. DOI: 10.1136/pgmj.2006.052688.